Consultant @ Generation Bio (January 2025 - May 2025)
Chief Scientific Officer @ Generation Bio (May 2019 - January 2025)
Head of Platform Research @ Generation Bio (October 2017 - May 2019)
Chief Technology Officer @ Newco at Atlas Ventures (October 2017 - January 2018)
Vice President, Head of Chemistry @ (April 2014 - September 2017)
Director, Chemistry @ Merck Research Laboratories, Merck & Co., Inc. (December 2008 - March 2014)
Associate, Equity Research @ (May 2008 - November 2008)
Research Fellow @ (August 1997 - May 2008)
Matthew Stanton Education
The University of North Carolina at Chapel Hill
Doctor of Philosophy (Ph.D.) (Chemistry)
2000-2003
The University of North Carolina at Chapel Hill
Master of Arts (M.A.) (Chemistry)
1995-1997
Virginia Tech
Bachelor of Science (B.S.) (Chemistry)
1992-1995
Matthew Stanton Skills
Biochemistry
Biomarker Discovery
Biotechnology
ChemDraw
Chemistry
Chromatography
Drug Design
Drug Development
Drug Discovery
Heterocyclic Chemistry
LC-MS
Lead Change
Lifesciences
Medicinal Chemistry
NMR
Organic Chemistry
Organic Synthesis
Organometallic Chemistry
Purification
RNAi
Small Molecules
Synthetic Organic Chemistry
Lc Ms
Synthetic Organic
Networking
Business Development
Marketing
RNA
Public Speaking
Matthew Stanton Summary
Matthew Stanton, based in Cambridge, MA, US, is currently a Chief Executive Officer at Typewriter Therapeutics, Inc.. Matthew Stanton brings experience from previous roles at Raven (RA Ventures), RA Capital Management and Generation Bio. Matthew Stanton holds a 2000 - 2003 Doctor of Philosophy (Ph.D.) in Chemistry @ The University of North Carolina at Chapel Hill. With a robust skill set that includes Biochemistry, Biomarker Discovery, Biotechnology, ChemDraw, Chemistry and more. Matthew Stanton has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Matthew Stanton?
Find contact details for 700 million professionals.